Clinical Trial Update: Kesimpta (Ofatumumab) Pregnancy Registry

View source ↗

Summary

This clinical trial update describes a Kesimpta (ofatumumab) pregnancy registry that is currently recruiting to collect safety data on pregnancy outcomes in peo…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Multiple Sclerosis

Drugs mentioned

• Kesimpta (ofatumumab)

Snippet

Sponsor: Novartis Pharmaceuticals | Conditions: Multiple Sclerosis, Pregnancy | Status: RECRUITING